Catalyst Wire Dossier Catalyst Wire Dossier

Furuitinib

Furuitinib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Furuitinib, covering 2025-02-12 to 2025-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer [Phase 1]

See pricing